IP Library › Granted Patent US 12,331,327
Granted Patent B2
US 12,331,327 · App. 18/046,295 · Granted Jun 17, 2025

Carboxyesterase biocatalysts

Inventors: Kristin K. Brown (Collegeville, PA); Brent M. Dorr (Collegeville, PA); Douglas E. Fuerst (Collegeville, PA); Katherine Joyce Honicker (Collegeville, PA); Lydia Sanchez Jordan (Collegeville, PA); James Patrick Morrison (Collegeville, PA); Nikolay V. Plotnikov (Collegeville, PA); Markus Schober (Stevenage, GB); Rama Voladri (Redwood City, CA)
Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
C12N9/18C12P17/16C12P17/165C12Y301/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,331,327
App. No.
18/046,295
Granted
Jun 17, 2025
Kind
B2
Abstract

The present disclosure provides engineered carboxyesterase enzymes that have the ability to catalyze amide bond formation. Also provided are polynucleotides encoding the carboxyesterase enzymes, host cells capable of expressing the engineered carboxyesterase enzymes, and methods of using the engineered carboxyesterase enzymes to make commercially valuable amides. Also provided are amides that are made using the engineered carboxyesterase enzymes.

Claims (28)

1. A carboxyesterase polypeptide comprising an amino acid sequence that is at least 90% identical to the amino acid sequence set forth in SEQ ID NO: 4, wherein the residue corresponding to X198 in SEQ ID NO: 4 is a phenylalanine (F) residue, an isoleucine (I) residue, a tyrosine (Y) residue, a leucine (L) residue, or a methionine (M) residue.

2. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide further comprises a residue difference as compared to the amino acid sequence set forth in SEQ ID NO: 4 in at least one residue position selected from the group consisting of: X27, X30, X35, X37, X57, X75, X103, X185, X207, X208, X271, X286, and X296.

3. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide further comprises at least one feature selected from the group consisting of:

the residue corresponding to X27 is a constrained residue;

the residue corresponding to X30 is an aliphatic residue;

the residue corresponding to X35 is chosen from a basic residue and a polar residue;

the residue corresponding to X37 is chosen from an aliphatic residue and a polar residue;

the residue corresponding to X57 is a non-polar residue;

the residue corresponding to X75 is chosen from a basic residue and a polar residue;

the residue corresponding to X103 is chosen from an aliphatic residue and an aromatic residue;

the residue corresponding to X185 is chosen from a non-polar residue, an aliphatic residue, and an aromatic residue;

the residue corresponding to X207 is chosen from an acidic residue and a polar residue;

the residue corresponding to X208 is chosen from an aliphatic residue, a basic residue, and a polar residue;

the residue corresponding to X271 is chosen from an acidic residue and a polar residue;

the residue corresponding to X286 is chosen from a non-polar residue, an aliphatic residue, a polar residue, and a small residue; and

the residue corresponding to X296 is chosen from an aliphatic residue and a basic residue.

4. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide further includes at least one feature selected from the group consisting of: X27 is P; X30 is I, L, or V; X35 is H; X37 is I, L, T, or V; X57 is M; X75 is R; X103 is F, M, or W; X185 is F, I, or M; X207 is E; X208 is R, L, or H; X271 is D; X286 is M, V, or G; and X296 is V, L, or R.

5. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide further includes the following features: X35 is chosen from a basic residue and a polar residue; and XI185 is chosen from a polar residue and an aliphatic residue.

6. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide further includes the following features: X35 is H; and XI185 is chosen from F, I, and M.

7. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 91% identical to the amino acid sequence set forth in SEQ ID NO: 4.

8. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 92% identical to the amino acid sequence set forth in SEQ ID NO: 4.

9. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 93% identical to the amino acid sequence set forth in SEQ ID NO: 4.

10. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 94% identical to the amino acid sequence set forth in SEQ ID NO: 4.

11. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 95% identical to the amino acid sequence set forth in SEQ ID NO: 4.

12. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 96% identical to the amino acid sequence set forth in SEQ ID NO: 4.

13. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 97% identical to the amino acid sequence set forth in SEQ ID NO: 4.

14. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 98% identical to the amino acid sequence set forth in SEQ ID NO: 4.

15. The carboxyesterase polypeptide of claim 1 , wherein the amino acid sequence of the carboxyesterase polypeptide is at least 99% identical to the amino acid sequence set forth in SEQ ID NO: 4.

Assignments (4)
CHANGE OF ADDRESS Recorded Oct 8, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 073032/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: BROWN, KRISTIN K.; DORR, BRENT M.; FUERST, DOUGLAS E.; HONICKER, KATHERINE JOYCE; JORDAN, LYDIA SANCHEZ; MORRISON, JAMES PATRICK; PLOTNIKOV, NIKOLAY V.; SCHOBER, MARKUS
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 070261/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: VOLADRI, RAMA
To: CODEXIS, INC.
Reel/Frame 070261/0869 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: CODEXIS, LTD.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 070262/0036 →
Continuity (3)
Continuation 16771279
Provisional Application 62598181 · Dec 13, 2017
Related Publication 20230193227A1 · Jun 22, 2023
References Cited (68)
US 6537746B2 · Arnold et al. · 2003 [cited by applicant]
US 20020137171A1 · Short et al. · 2002 [cited by applicant]
US 20060195947A1 · Davis et al. · 2006 [cited by applicant]
US 20080248539A1 · Giver et al. · 2008 [cited by applicant]
US 20210115417A1 · Brown et al. · 2021 [cited by applicant]
CN 106754818A · 2017 [cited by applicant]
WO WO1995022625 · 1995 [cited by applicant]
WO WO1997000078 · 1997 [cited by applicant]
WO WO1997035966 · 1997 [cited by applicant]
WO WO1998027230 · 1998 [cited by applicant]
WO WO2000042651 · 2000 [cited by applicant]
WO WO2001075767 · 2001 [cited by applicant]
WO WO2002057411 · 2002 [cited by applicant]
WO 2004026871A1 · 2004 [cited by applicant]
WO WO2005032496 · 2005 [cited by applicant]
WO WO2006096834 · 2006 [cited by applicant]
WO WO2007092314 · 2007 [cited by applicant]
WO 2010111622A2 · 2010 [cited by applicant]
Altschul et al., “Basic local alignment search tool,” J Mal. Biol., 1990, 215:403-410. [cited by applicant]
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Res., 1977, 3389-3402. [cited by applicant]
Anonymous: “Uni Prot: A0A1N7LKA1”, Mar. 5, 2017, XP055560136, retrieved from the Internet: URL: http://ibis.internal.epo.org/exam/dbfetch.jsp?id=UNIPROT:A0A1N7LKAI [retrieved on Feb. 21, 2019] the whole document. [cited by applicant]
Beaucage et al., “Deoxynucleoside phosphoramidites—a new class of key intermediates for deoxypolynucleotide synthesis,” Tet Lett., 1981, 22:1859-69. [cited by applicant]
Black et al., “Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy,” Proc Natl Acad Sci USA, 1996, 93:3525-3529. [cited by applicant]
Botstein et al., “Strategies and applications of in vitro mutagenesis,” Science, 1985, 229: 1193-1201. [cited by applicant]
Caldwell et al., “Mutagenic PCR,” PCRMethods Appl., 1994, 3:S136-S140. [cited by applicant]
Carter, “Site-directed mutagenesis,” Biochem. J, 1986, 237:1-7. [cited by applicant]
Christians et al., “Directed evolution ofthymidine kinase for AZT phosphorylation using DNA family shuffling,” Nature Biotech, 1999, 17:259-264. [cited by applicant]
Crameri et al., “DNA shuffling of a family of genes from diverse species accelerates directed evolution,” Nature, 1998, 391:288-291. [cited by applicant]
Crameri et al., “Improved green fluorescent protein by molecular evolution using DNA shuffling,” Nature Biotech, 1996, 14:315-319. [cited by applicant]
Crameri et al., “Molecular evolution of an arsenate detoxification pathway by DNA shuffling,” Nature Biotech, 1997, 15:436-438. [cited by applicant]
Dale et al., “Oligonucleotide-directed random mutagenesis using the phosphorothioate method,” Methods Mal. Biol., 1996, 57:369-74. [cited by applicant]
Database UniProt [online], Mar. 15, 2017, “SubName: Full=Acetyl esterase {EC0″0000313:EMBL:SIS74246.1},” XP55560136, retrieve from EBI accession No. UNIPROT:A0AN7LKA1 Database accession No. AOAIN7LKAI sequence. [cited by applicant]
de Figueiredo et al., “Nonclassical Routes for Amide Bond Formation,” Chemical Reviews, 2016, 12029-12122. [cited by applicant]
Devos et al., “Practical Limits of Function Prediction,” Proteins: Structure, Function and Genetics, 2000, 41: 98-107. [cited by applicant]
Eisenberg et al., “Analysis of membrane and surface protein sequences with the hydrophobic moment plot,” J Mal. Biol., 1984, 179:125-142. [cited by applicant]
GenBank Accession No. WP_076345770.1, “alpha/beta hydrolase [Alicyclobacillus vulcanalis],” dated Jan. 21, 2017, 1 page. [cited by applicant]
Gotor, “Non-conventional hydrolase chemistry: amide and carbamate bond formation catalyzed by lipases,” Bioorg Med Chem, 1999, 7:2189-2197. [cited by applicant]
Henaut and Danchin, “Analysis and predictions from [cited by applicant]
Henikoff and Henikoff, “Amino acid substitution matrices from protein blocks,” Proc NatlAcad Sci USA, 1989, 89:10915. [cited by applicant]
Kisselev, “Polypeptide Release Factors in Prokaryotes and Eukaryotes: Same Function, Different Structure,” Structure, Jan. 2002, 10: 8-9. [cited by applicant]
Kramer et al., “Point Mismatch Repair,” Cell, 1984, 38:879-887. [cited by applicant]
Ling et al., “Approaches to DNA mutagenesis an overview,” Anal. Biochem., 1997, 254(2):157-78. [cited by applicant]
Matthes, et al., “Simultaneous rapid chemical synthesis of over one hundred oligonucleotides on a microscale,” EMBO J, 1984, 3:801-05. [cited by applicant]
Mcinerney, “GCUA: general codon usage analysis,” Bioinformatics, 1998, 14:372-73. [cited by applicant]
Minshull et al., “Protein evolution by molecular breeding,” Curr Opin Chem Biol, 1999, 3:284-290. [cited by applicant]
Nakamura, et al., “Codon usage tabulated from international DNA sequence databases: status for the year 2000,” Nucl. Acids Res., 2000, 28:292. [cited by applicant]
Needleman and Wunsch, “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” J Mal. Biol., 1970, 48:443. [cited by applicant]
Pattabiraman and Bode, “Rethinking amide bond synthesis,” Nature, 2011, 480:471-479. [cited by applicant]
PCT International Preliminary Report on Patentability in International Appln. No. PCT/IB2018/060042, dated Jun. 16, 2020, 7 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/IB2018/060042, dated Mar. 15, 2019, 11 pages. [cited by applicant]
Pearson and Lipman, “Improved tools for biological sequence comparison,” Proc. Natl. Acad. Sci. USA, 1988, 85:2444. [cited by applicant]
Schneider et al., “Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists' Bread and Butter,” J Med. Chem., 2016, 59:4385-4402. [cited by applicant]
Smith and Waterman, “Comparison of biosequences,” Adv. Appl. Math., 1981, 2:482. [cited by applicant]
Smith, “In vitro mutagenesis,” Ann. Rev. Genet., 1985, 19:423-462. [cited by applicant]
Stemmer, “DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution,” Proc Natl Acad Sci USA, 1994, 91:10747-10751. [cited by applicant]
Stemmer, “Rapid evolution of a protein in vitro by DNA shuffling,” Nature, 1994, 370:389-391. [cited by applicant]
Stenico et al., “Codon usage in Caenorhabditis elegans: delineation of translational selection and mutational biases,” Nucleic Acids Res., 1994, 22:2437-46. [cited by applicant]
Tiwari et al., “Prediction of probable genes by Fourier analysis of genomic sequences,” Comput. Appl. Biosci., 1997, 13:263-270. [cited by applicant]
Uberbacher et al., “Discovering and understanding genes in human DNA sequence using GRAIL,” Methods Enzymol., 1996, 266:259-281. [cited by applicant]
van Pelt, “Pseudomonas stutzerilipase: a useful biocatalyst for aminolysis reactions,” Green, Chem., 2011. 13:1791-1798. [cited by applicant]
Wada et al., “Codon usage tabulated from the GenBank genetic sequence data,” Nucleic Acids Res., 1992, 20:2111-2118. [cited by applicant]
Wells et al., “Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites,” Gene, 1985, 34:315-323. [cited by applicant]
Whisstock et al., “Prediction of protein function from protein sequence and structure,” Quarterly Reviews of Biophysics, 2003, 36(3): 307-340. [cited by applicant]
Witkowski et al., “Conversion of a B-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine,” Biochemistry, 1999, 38:11643-11650. [cited by applicant]
Wright, “The ‘effective number of codons’ used in a gene,” Gene, 1990, 87:23-29. [cited by applicant]
Zhang et al., 1997, “Directed evolution of an effective fructosidase from a galactosidase by DNA shuffling and screening,” Proc Natl Acad Sci USA, 1997, 94:4504-4509. [cited by applicant]
Zhao et al., “Molecular evolution by staggered extension process (StEP) in vitro recombination,” Nat. Biotechnol., 1998, 16:258-261. [cited by applicant]
GenBank Accession No. WPJ312812080.1, dated May 17, 2013. [cited by applicant]